Abstract
EE715 Faricimab Vs. Standard of Care in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Cost-Utility Analysis in Italy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have